Literature DB >> 15857460

Case-control study to identify melanoma risk factors in the Belgian population: the significance of clinical examination.

T Nijsten1, C Leys, K Verbruggen, V Verlinden, J Drieghe, M Stas, J Lambert, H DeGreef, M Garmyn.   

Abstract

BACKGROUND: Although numerous studies have evaluated risk factors associated with cutaneous malignant melanoma (CMM), no such study has been carried out in Belgium.
OBJECTIVES: To identify individuals who are at high risk of developing malignant melanoma in Belgium, which could enhance the efficacy of screening interventions and avoid unnecessary skin inspections. STUDY DESIGN/SETTING/
SUBJECTS: We prospectively included patients who were diagnosed with invasive malignant melanoma between 1998 and 2001 at the Department of Dermatology in a case-control study. Controls were selected from the outpatient dermatology clinic. Participants were interviewed and clinically examined by a dermatologist. We asked questions concerning most known risk factors associated with malignant melanoma such as phenotypical and skin characteristics, and environmental and lifestyle exposures. To adjust for confounding variables and to estimate odds ratios (ORs) and 95% confidence intervals (CIs), a multivariate model was used.
RESULTS: Although sunburn in childhood and substantial occupational solar exposure were modestly, but significantly, associated with malignant melanoma risk, clinical examination yielded several stronger risk factors. In a multivariate model, which adjusted for age, gender and skin phototype, phenotypical characteristics such as skin, hair and eye colour were significantly associated with the development of malignant melanoma. In the multivariate model, people with three or more atypical naevi were at more than 10-fold risk of developing a malignant melanoma (> or = 3 atypical naevi; adjusted OR = 11.40, 95% CI = 4.79-17.53) compared to those without an atypical naevus. The presence of one or more palpable naevi on the upper extremities or having solar lentigines increased the odds of developing malignant melanoma at least twofold.
CONCLUSIONS: In Belgium, risk factors associated with malignant melanoma appear to be in accordance with previous studies. To assess peoples' risk profile, clinical skin examination is likely to yield the most important sporadic malignant melanoma risk factors. Therefore, focusing screening campaigns on individuals with predefined findings on skin self-examination may increase its efficacy.

Entities:  

Mesh:

Year:  2005        PMID: 15857460     DOI: 10.1111/j.1468-3083.2005.01196.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  6 in total

1.  MelaNostrum: a consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the melanostrum consortium.

Authors:  Alexander J Stratigos; Maria Concetta Fargnoli; Arcangela De Nicolo; Ketty Peris; Susana Puig; Efthymia Soura; Chiara Menin; Donato Calista; Paola Ghiorzo; Mario Mandala; Daniela Massi; Monica Rodolfo; Laura Del Regno; Irene Stefanaki; Helen Gogas; Veronique Bataille; Margaret A Tucker; David Whiteman; Eduardo Nagore; Maria Teresa Landi
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-09-14       Impact factor: 6.166

2.  Identifying risk factors using a skin cancer screening program.

Authors:  Jeremy R Etzkorn; Rajiv P Parikh; Suroosh S Marzban; Kimberly Law; Ashley H Davis; Bhupendra Rawal; Michael J Schell; Vernon K Sondak; Jane L Messina; Lois E Rendina; Jonathan S Zager; Mary H Lien
Journal:  Cancer Control       Date:  2013-10       Impact factor: 3.302

3.  Prevention of malignant melanoma.

Authors:  G Chaidemenos; A Stratigos; M Papakonstantinou; F Tsatsou
Journal:  Hippokratia       Date:  2008-01       Impact factor: 0.471

4.  Sunburns and risk of cutaneous melanoma: does age matter? A comprehensive meta-analysis.

Authors:  Leslie K Dennis; Marta J Vanbeek; Laura E Beane Freeman; Brian J Smith; Deborah V Dawson; Julie A Coughlin
Journal:  Ann Epidemiol       Date:  2008-08       Impact factor: 3.797

5.  Ethnicity and cutaneous melanoma in the city of Sao Paulo, Brazil: a case-control study.

Authors:  Olinda C Luiz; Reinaldo José Gianini; Fernanda T Gonçalves; Guilherme Francisco; Cyro Festa-Neto; José Antonio Sanches; Gilka J F Gattas; Roger Chammas; José Eluf-Neto
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

Review 6.  Current Data on Risk Factor Estimates Does Not Explain the Difference in Rates of Melanoma between Hispanics and Non-Hispanic Whites.

Authors:  Sonia Kamath; Kimberly A Miller; Myles G Cockburn
Journal:  J Skin Cancer       Date:  2016-03-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.